CSDA inhibitors constitute a specialized class of chemical compounds that have gained recognition in the field of molecular biology and gene regulation research. CSDA, or Cold Shock Domain-Containing Protein A, is a protein known for its involvement in various cellular processes, including transcriptional regulation, mRNA stabilization, and stress responses. The term CSDA inhibitors refers to a group of molecules meticulously designed to selectively target and modulate the activity of CSDA. These inhibitors serve as indispensable tools in laboratory investigations, enabling researchers to explore the intricate molecular functions and cellular processes associated with CSDA.
CSDA inhibitors typically function by interfering with the binding of CSDA to its target RNA molecules or by modulating its interactions with other cellular proteins and regulatory elements. This interference can lead to alterations in RNA stability, gene expression patterns, and cellular responses to stressors, impacting various aspects of cellular biology and adaptation. Researchers employ CSDA inhibitors to gain insights into the physiological roles and molecular interactions of CSDA within cells, aiming to advance our understanding of the fundamental mechanisms involved in gene regulation, RNA metabolism, and stress responses. Through the study of CSDA inhibitors, scientists seek to unravel the complexities of cellular processes and molecular interactions that govern gene expression, RNA biology, and the broader field of molecular and cellular biology, contributing to our knowledge of how cells respond to environmental cues and maintain genomic stability.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, potentially reducing CSDA mRNA synthesis and thus its protein expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB is an inhibitor of RNA polymerase II transcription elongation which may decrease CSDA gene expression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases and may reduce transcription of genes, including CSDA. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA synthesis, which could decrease CSDA expression by preventing mRNA transcription. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide is known to inhibit transcription factors and may reduce CSDA expression through suppression of gene transcription. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $115.00 $337.00 | 3 | |
Betulinic acid can modulate transcription factors, possibly reducing transcription levels of the CSDA gene. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $110.00 $386.00 | 8 | |
Oxaliplatin forms DNA adducts, which may interfere with transcription and thus reduce CSDA expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin forms DNA cross-links that can inhibit transcription and potentially decrease CSDA mRNA levels. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to G-C rich DNA sequences, potentially downregulating gene expression, including CSDA. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Cordycepin is an adenosine analog that can terminate RNA chain elongation, possibly affecting CSDA mRNA stability. | ||||||